Sarepta Therapeutics Inc (SRPT)

Exchange
NASDAQ
Symbol
SRPT
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    126.50
  • High
    128.32
  • Low
    122.45
  • Close
    127.97
  • Volume
    1,384,800

Financial ratios

Mar 31, 2024

Activity ratios
Inventory turnover
1.42
Receivables turnover
3.70
Payables turnover
5.79
Working capital turnover
0.76
Days of inventory on hand (DOH)
257.17
Days of sales outstanding (DSO)
98.53
Number of days of payables
63.02
Fixed asset turnover
5.63
Total asset turnover
0.44
 Liquidity ratios
Current ratio
4.05
Quick ratio
2.91
Cash ratio
2.28
Cash conversion cycle
292.68
 Solvency ratios
Debt-to-assets ratio
0.35
Debt-to-capital ratio
0.54
Debt-to-equity ratio
1.18
Financial leverage ratio
3.35
Interest coverage
2.72
 Profitability ratios
Gross profit margin
62.22%
Operating profit margin
-6.76%
Pretax margin
2.43%
Net profit margin
1.20%
Operating return on assets (Operating ROA)
-2.94%
Return on assets (ROA)
0.52%
Return on total capital
2.57%
Return on equity (ROE)
1.76%